GlassScriptPhysician profile
Sami M Aasar
NPI 1427086974
$3,631.30
in general payments reported to CMS, 2019-2025
21 companies · $97.45 in 2025
The $97.45 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,413 · 2020: $961 · 2021: $162 · 2022: $425 · 2023: $483 · 2024: $90.12 · 2025: $97.45.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $670.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $670.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cardiovascular Systems INC. | $2,144.68 | 2019-2020 | |
| Boston Scientific Corporation | $469.06 | 2019-2025 | Altrua 20, Advantio, Dynagen Mini Icd Vr |
| Janssen Pharmaceuticals, INC | $130.55 | 2023 | Xarelto |
| Penumbra, INC. | $124.71 | 2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $113.62 | 2023-2024 | Lifevest |
| Novartis Pharmaceuticals Corporation | $103.40 | 2021-2023 | |
| Abbott Laboratories | $92.86 | 2019-2020 | |
| Amgen INC. | $81.28 | 2020-2022 | |
| E.R. Squibb & Sons, L.L.C. | $51.51 | 2021-2023 | Camzyos |
| Biotronik INC. | $51.04 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $42.99 | 2021-2022 | |
| Medtronic Vascular, INC. | $38.18 | 2019-2020 | |
| Lantheus Medical Imaging, INC. | $34.84 | 2019 | |
| Alnylam Pharmaceuticals INC. | $26.34 | 2022 | |
| Terumo Medical Corporation | $24.54 | 2025 | Hydropearl |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $24.04 | 2023 | Linq II |
| Preventice Services, LLC | $21.77 | 2021 | |
| Bard Peripheral Vascular, INC. | $18.91 | 2019 | |
| Pfizer INC. | $14.57 | 2021 | |
| Cvrx, INC. | $12.41 | 2022 | |
| Bardy Diagnostics, INC. | $10.00 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sami Aasar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.